{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:45:51Z","timestamp":1777934751778,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pain management in patients with metastatic cancer is a major challenge. The aim of this study is to analyse opioid prescribing practices and evaluate their effectiveness as perceived by patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A descriptive, prospective study was conducted at the hospital pharmacy over a period of six months. Data were collected through direct interviews with patients. The study included patients diagnosed with metastatic cancer who were treated with opioids. The data collected concerned the demographic and clinical characteristics of the patients, as well as the prescription modalities, perceived efficacy and adverse effects of opioids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 144 patients were included, with a mean age of 49.5 years. The most frequent tumour site was the breast (25.9%). Metastases were predominantly bone metastases (52.4%). The intensity of perceived pain was high, with a score of \u22657 on the visual analogue scale in 94% of patients before the initiation of analgesic treatment. Morphine was the most commonly prescribed opioid (61.8%). Tramadol and the combination of paracetamol and codeine were also widely used. The perceived efficacy of opioids was positive for 78.5% of patients, with complete pain relief in 41.7%. However, 21.5% of patients reported persistent pain despite analgesic treatment. The leading adverse effect was constipation (39%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion\/Conclusion<\/jats:title>\n                    <jats:p>This study highlights the importance of pain management, one of the four core components of supportive cancer care, with morphine remaining the opioid of choice for providing effective analgesia. However, the high frequency of adverse effects underscores the need for improved symptomatic management strategies. This study has several limitations. Nevertheless, it provides valuable real-world insights into opioid use in cancer pain management and emphasizes the need for larger, multicenter studies to validate and further expand these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261440200","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:37:28Z","timestamp":1776094648000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain and metastatic cancer: Opioid prescribing practices and perceptions of their effectiveness"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3262-9186","authenticated-orcid":false,"given":"Khadija Ben","family":"Chaabane","sequence":"first","affiliation":[{"name":"Principal Military Hospital of Instruction of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oussema","family":"Slimani","sequence":"additional","affiliation":[{"name":"Institute Salah Aza\u00efz of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raafa Ben","family":"Saada","sequence":"additional","affiliation":[{"name":"Principal Military Hospital of Instruction of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze\u00efneb","family":"Zghal","sequence":"additional","affiliation":[{"name":"Principal Military Hospital of Instruction of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ali","family":"Yousfi","sequence":"additional","affiliation":[{"name":"Principal Military Hospital of Instruction of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Limayem","sequence":"additional","affiliation":[{"name":"Institute Salah Aza\u00efz of Tunis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"182","article-title":"Caract\u00e9ristiques de la prise en charge en th\u00e9rapie antalgique intrath\u00e9cale aux centres sp\u00e9cialis\u00e9s en France","volume":"21","author":"Silva CC","year":"2020","unstructured":"Silva CC, Schoch JP, De Larminat V, et al. Caract\u00e9ristiques de la prise en charge en th\u00e9rapie antalgique intrath\u00e9cale aux centres sp\u00e9cialis\u00e9s en France. Douleurs Eval Diagn Trait 2020; 21: 182\u2013190.","journal-title":"Douleurs Eval Diagn Trait"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1138169"},{"key":"e_1_3_2_4_2","first-page":"127","article-title":"Acc\u00e8s aux analg\u00e9siques opio\u00efdes pour les douleurs canc\u00e9reuses : des in\u00e9galit\u00e9s majeures \u2013 la situation en afrique","volume":"18","author":"Fellah N","year":"2017","unstructured":"Fellah N, Nejmi M, Rais H, et al. Acc\u00e8s aux analg\u00e9siques opio\u00efdes pour les douleurs canc\u00e9reuses : des in\u00e9galit\u00e9s majeures \u2013 la situation en afrique. Douleurs Eval Diagn Trait 2017; 18: 127\u2013139.","journal-title":"Douleurs Eval Diagn Trait"},{"key":"e_1_3_2_5_2","volume-title":"Data visualization tools for exploring the global cancer burden in 2022","author":"World Health Organizaion","year":"2022","unstructured":"World Health Organizaion. Data visualization tools for exploring the global cancer burden in 2022. Gen\u00e8ve: WHO, 2022."},{"key":"e_1_3_2_6_2","unstructured":"Gueziz AS Ouddane MA. Prise en charge des douleurs canc\u00e9reuses Etude prospective au niveau de l'unit\u00e9 d'oncologie m\u00e9dicale du CAC Ouargla du janvier 2023 \u00e0 mars 2023 [M\u00e9moire]. Ouergla : Facult\u00e9 de M\u00e9decine; 2023."},{"key":"e_1_3_2_7_2","volume-title":"Epid\u00e9miologie des cancers - Les chiffres du cancer en France","author":"Institut National du Cancer","year":"2024","unstructured":"Institut National du Cancer. Epid\u00e9miologie des cancers - Les chiffres du cancer en France. France: INCA, 2024."},{"key":"e_1_3_2_8_2","first-page":"141","article-title":"\u00c9pid\u00e9miologie et caract\u00e9ristiques clinicopathologiques du cancer du poumon dans le sud de la tunisie","volume":"15","author":"Khemakhem R","year":"2023","unstructured":"Khemakhem R, Elloumi O, Ghourabi A, et al. \u00c9pid\u00e9miologie et caract\u00e9ristiques clinicopathologiques du cancer du poumon dans le sud de la tunisie. Rev Mal Respir Actual 2023; 15: 141.","journal-title":"Rev Mal Respir Actual"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3922-0"},{"key":"e_1_3_2_10_2","first-page":"135","article-title":"Prise en charge des m\u00e9tastases osseuses de l\u2019ac\u00e9tabulum","volume":"108","author":"Vaz G","year":"2022","unstructured":"Vaz G, Gouin F. Prise en charge des m\u00e9tastases osseuses de l\u2019ac\u00e9tabulum. Rev Chir Orthop Traumatol 2022; 108: 135\u2013146.","journal-title":"Rev Chir Orthop Traumatol"},{"key":"e_1_3_2_11_2","first-page":"304","article-title":"Les m\u00e9tastases osseuses","volume":"25","author":"Villatte-De Figueiredo C","year":"2024","unstructured":"Villatte-De Figueiredo C. Les m\u00e9tastases osseuses. Douleurs Eval Diagn Trait 2024; 25: 304\u2013306.","journal-title":"Douleurs Eval Diagn Trait"},{"key":"e_1_3_2_12_2","unstructured":"Nabila B Bouzidi Dounia ZI. Les variations du bilan lipidique chez les canc\u00e9reux apr\u00e8s traitement par chimioth\u00e9rapie [M\u00e9moire]. Guelma: Universit\u00e9 8 Mai 1945 Guelma; 2021."},{"key":"e_1_3_2_13_2","unstructured":"Institut Salah Azaiez. Pr\u00e9sentation du service de la pharmacie [En Ligne]. 2025 [Consult\u00e9 le 24\/01\/2025]. Disponible sur: https:\/\/www. institutsalahazaiez.com\/offre-de-soins.php?id=13."},{"key":"e_1_3_2_14_2","first-page":"12","article-title":"Des agents cytotoxiques \u00e0 la chimioth\u00e9rapie orale, un r\u00f4le renforc\u00e9 pour l\u2019\u00e9quipe officinale","volume":"62","author":"Buxeraud J","year":"2023","unstructured":"Buxeraud J, Faure S. Des agents cytotoxiques \u00e0 la chimioth\u00e9rapie orale, un r\u00f4le renforc\u00e9 pour l\u2019\u00e9quipe officinale. Actual Pharm 2023; 62: 12\u201316.","journal-title":"Actual Pharm"},{"key":"e_1_3_2_15_2","first-page":"17","article-title":"Nouveaux d\u00e9fis dans le traitement du cancer du sein HER2 positif localis\u00e9","volume":"6","author":"Ricci F","year":"2020","unstructured":"Ricci F, Loirat D. Nouveaux d\u00e9fis dans le traitement du cancer du sein HER2 positif localis\u00e9. Innov Th\u00e9r Oncol 2020; 6: 17\u201324.","journal-title":"Innov Th\u00e9r Oncol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm056"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2016.08.007"},{"key":"e_1_3_2_18_2","volume-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Gen\u00e8ve: WHO, 2018."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.08.006"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2020.12.013"},{"key":"e_1_3_2_21_2","unstructured":"Boulanger T. Les Formes Pharmaceutiques et les voies d\u2019administration [En Ligne]. 2014 [Consult\u00e9 le 02\/03\/2025]. Disponible sur : https:\/\/www.ch-carcassonne.fr\/imgfr\/files\/lesformespharmaceutiquesetlesvoiesdadministrationdrboulanger.pdf."},{"key":"e_1_3_2_22_2","unstructured":"Ammann M Beaud M. Quels sont les freins \u00e0 l\u2019utilisation des opiac\u00e9s dans la gestion de la douleur induite en p\u00e9diatrie[Th\u00e8se]. Fribourg : Haute Ecole de Sant\u00e9; 2019."},{"key":"e_1_3_2_23_2","first-page":"397","article-title":"Douleur et m\u00e9canismes inconscients","volume":"204","author":"Laurent B","year":"2020","unstructured":"Laurent B, Peyron R, Bastuji H, et al. Douleur et m\u00e9canismes inconscients. Bull Acad Natl Med 2020; 204: 397\u2013403.","journal-title":"Bull Acad Natl Med"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxaa134"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.banm.2021.10.005"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amp.2023.06.005"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2022.07.011"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2018.07.002"},{"key":"e_1_3_2_29_2","first-page":"31","article-title":"Les m\u00e9dicaments de la douleur","volume":"60","author":"Coudert P","year":"2021","unstructured":"Coudert P, Decrozant E. Les m\u00e9dicaments de la douleur. Actual Pharm 2021; 60: 31\u201335.","journal-title":"Actual Pharm"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.09.016"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261440200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261440200","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261440200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:32:38Z","timestamp":1777689158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261440200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":29,"alternative-id":["10.1177\/10781552261440200"],"URL":"https:\/\/doi.org\/10.1177\/10781552261440200","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"10781552261440200"}}